A critical advance in cancer research is arising with the use of mini-antibodies to reactivate mutated p53. This crucial tumor suppressor protein is frequently disabled in many forms of tumors, resulting uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research